From Zero to One:
Eroom’s law — that’s Moore’s law backward — observes that the number of new drugs approved per billion dollars spent on R&D has halved every nine years since 1950.
Update: Here’s an article from Nature that gives more details. The trend is pretty flat on a log scale, i.e. exponentially declining efficiency.
Related: Adaptive clinical trial design